WallStreetZenWallStreetZen

NASDAQ: MDVL
Medavail Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

MDVL past revenue growth

How has MDVL's revenue growth performed historically?
Company
117.5%
Industry
255.23%
Market
17.24%
MDVL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MDVL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MDVL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MDVL earnings and revenue history

Current Revenue
$39.0M
Current Earnings
-$49.2M
Current Profit Margin
-126%

MDVL Return on Equity

Current Company
-219.1%
Current Industry
12.4%
Current Market
-9.5%
MDVL's Return on Equity (-219.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MDVL announces earnings.

MDVL Return on Assets

Current Company
-116.7%
Current Industry
3.8%
MDVL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MDVL Return on Capital Employed

Current Company
-112.26%
Current Industry
7.9%
MDVL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MDVL vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MDVL$39.04M-$44.24M-$49.17M+150.47%N/A
ZYNE$0.00-$34.82M-$35.04M-100.00%N/A
FLGCN/AN/AN/AN/AN/A
RMTI$72.81M-$14.15M-$18.68M+4.91%N/A
PAVS$95.59M-$56.22M-$58.51M+79.21%N/A
View Top Pharmaceutical Stocks

MDVL earnings dates

Next earnings date
May 11, 2023

Medavail Holdings Earnings & Revenue FAQ

What were MDVL's earnings last quarter?

On Invalid Date, Medavail Holdings (NASDAQ: MDVL) reported Q3 2022 earnings per share (EPS) of -$0.15, up 55.88% year over year. Total Medavail Holdings earnings for the quarter were -$11.81 million. In the same quarter last year, Medavail Holdings's earnings per share (EPS) was -$0.34.

If you're new to stock investing, here's how to buy Medavail Holdings stock.

What was MDVL's earnings growth in the past year?

As of Q2 2023, Medavail Holdings's earnings has grown year over year. Medavail Holdings's earnings in the past year totalled -$49.17 million.

What is MDVL's earnings date?

Medavail Holdings's earnings date is Invalid Date. Add MDVL to your watchlist to be reminded of MDVL's next earnings announcement.

What was MDVL's revenue last quarter?

On Invalid Date, Medavail Holdings (NASDAQ: MDVL) reported Q3 2022 revenue of $11.46 million up 97.88% year over year. In the same quarter last year, Medavail Holdings's revenue was $5.79 million.

What was MDVL's revenue growth in the past year?

As of Q2 2023, Medavail Holdings's revenue has grown 117.5% year over year. This is 137.73 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 255.23%. Medavail Holdings's revenue in the past year totalled $39.04 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.